Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06133322 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Blood Pressure Lowering Strategies to Eliminate Hypertension Disparities (BLESSED)

Study acronym: BLESSED
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 10 months later Aug 31, 2026 → Jun 30, 2027
See other at-risk trials from Tulane University

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Aug 31, 2026 to Jun 30, 2027 Show 4 more changesShow less
    • Interventions: Behavioral: Evidence-based interventions recommended by the 2017 ACC/AHA hypertension clinical guideline (Behavioral) to Behavioral: Evidence-based interventions recommended by the 2017 ACC/AHA hypertension clinical guideline (Behavioral)
    • Eligibility criteria expanded, about 10 words
    • Secondary endpoints: details revised at 16 of 23 entries
    • Publications: details revised at 3 of 3 entries
  2. Site contact updated
    • Eligibility criteria shortened, about 4 words
    • Study description expanded, about 2 words
    v4
  3. Primary completion date: Aug 2027 to Aug 31, 2026
    • Study completion date: Aug 2028 to Jun 30, 2027
    v3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Nov 2023 to Nov 1, 2023
    • Site details revised
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Tulane University
47 trials monitored
See 8 trials at risk
Hypertension
1,925 trials monitored
See 99 trials at risk
The burden of hypertension and related cardiovascular diseases, stroke, and end-stage kidney disease is disproportionately high in Black populations, especially in the South. The Blood Pressure Lowering Strategies to Eliminate Hypertension Disparities (BLESSED) cluster randomized trial aims to test the effectiveness, implementation, and sustainability of a community health worker (CHW)-led multifaceted intervention compared to enhanced usual care for hypertension control in Black communities. In the BLESSED trial, the investigators plan to recruit 1,176 adults with hypertension (approximately 28 per church) from 42 predominantly Black churches in the Greater New Orleans area. The multifaceted intervention will last for 18 months, followed by a post-intervention follow-up visit at 24 months. The BLESSED trial aims to generate evidence regarding the effectiveness, implementation, and sustainability of this CHW-led church-based multifaceted intervention in eliminating hypertension disparities in the United States (US) general population.
Trial Details
NCT Number NCT06133322
Lead Sponsor Tulane University
Collaborators: National Institutes of Health (NIH), National Institute on Minority Health and Health Disparities (NIMHD)
Conditions
(from sponsor)		 Hypertension
Related terms Hypertension
Enrollment 1,176 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov